Viking Therapeutics, Inc. (VKTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$32.51
Day's range
$33.8

Viking Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 01/29/2026 9.98 M $351.25 M   -0.15% 8.86%
BLACKROCK, INC. 02/12/2026 6.61 M $232.61 M   18.15% 5.87%
FMR LLC 02/17/2026 6.56 M $230.70 M   13.26% 5.75%
STATE STREET CORP 02/13/2026 4.45 M $156.39 M   -1.52% 3.95%
MORGAN STANLEY 02/13/2026 3.08 M $108.22 M   -17.51% 2.73%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 2.98 M $104.80 M   50.81% 2.64%
TWO SIGMA INVESTMENTS, LP 02/17/2026 2.44 M $85.69 M   16.79% 2.16%
TWO SIGMA ADVISERS, LP 02/17/2026 2.13 M $74.91 M   36.92% 1.89%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.99 M $70.18 M   23.99% 1.77%
CITADEL ADVISORS LLC 02/17/2026 1.73 M $60.95 M   -8.74% 1.54%
D. E. SHAW & CO., INC. 02/17/2026 1.72 M $60.46 M   965.03% 1.51%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 1.56 M $54.76 M   -12.18% 1.38%
JANE STREET GROUP, LLC 02/12/2026 1.50 M $52.81 M   89.10% 1.34%
CITADEL ADVISORS LLC 02/17/2026 1.44 M $50.50 M   13.24% 1.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 1.42 M $50.09 M   -32.18% 1.26%
AMERIPRISE FINANCIAL INC 02/17/2026 1.34 M $47.11 M   -36.02% 1.17%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 992.70 K $34.92 M   535.09% 0.88%
CITADEL ADVISORS LLC 02/17/2026 935.60 K $32.91 M   -24.10% 0.83%
UBS GROUP AG 01/29/2026 934.93 K $32.89 M   -30.35% 0.83%
RAYMOND JAMES FINANCIAL INC 02/18/2026 922.00 K $32.44 M   -3.38% 0.81%
GOLDMAN SACHS GROUP INC 03/25/2026 832.65 K $29.29 M   210.99% 0.74%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 752.73 K $26.48 M   -37.08% 0.67%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/17/2026 722.20 K $25.41 M   253.69% 0.64%
ARTIA GLOBAL PARTNERS LP 02/17/2026 719.37 K $25.31 M   392.11% 0.64%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 700.30 K $24.64 M   0.37% 0.61%
DIADEMA PARTNERS LP 02/17/2026 688.90 K $24.24 M   70.06% 0.61%
JANE STREET GROUP, LLC 02/12/2026 636.00 K $22.37 M   -9.85% 0.57%
BLACKBARN CAPITAL PARTNERS LP 02/17/2026 550.00 K $19.35 M   10.00% 0.49%
JPMORGAN CHASE & CO 02/11/2026 546.83 K $19.24 M   -78.78% 0.49%
NORTHERN TRUST CORP 02/17/2026 541.05 K $19.03 M   -2.91% 0.47%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 518.80 K $18.25 M   -4.67% 0.46%
BARCLAYS PLC 02/13/2026 516.66 K $18.18 M   12.12% 0.46%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 513.73 K $18.07 M   -0.05% 0.46%
TANG CAPITAL MANAGEMENT LLC 02/17/2026 500.00 K $17.59 M   -42.53% 0.44%
BANK OF NEW YORK MELLON CORP 02/10/2026 474.62 K $16.70 M   -5.04% 0.42%
ROYAL BANK OF CANADA 02/17/2026 455.42 K $16.02 M   -29.75% 0.40%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 459.58 K $16.17 M   -2.48% 0.40%
CLEARBRIDGE INVESTMENTS, LLC 02/11/2026 444.84 K $15.65 M   0.14% 0.39%
BLAIR WILLIAM & CO/IL 02/17/2026 423.96 K $14.92 M   19.12% 0.38%
FIRST WASHINGTON CORP 02/13/2026 387.53 K $13.63 M   45.23% 0.34%
WALLEYE TRADING LLC 02/13/2026 389.80 K $13.71 M   -2.21% 0.34%
BANK OF AMERICA CORP /DE/ 02/17/2026 346.65 K $12.20 M   -40.05% 0.31%
DIADEMA PARTNERS LP 02/17/2026 336.85 K $11.85 M   73.91% 0.30%
STIFEL FINANCIAL CORP 02/13/2026 336.82 K $11.85 M   -3.87% 0.30%
MACQUARIE MANAGEMENT HOLDINGS, INC. 02/17/2026 330.10 K $11.61 M   100.00% 0.29%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/17/2026 326.40 K $11.47 M   1,532.00% 0.29%
DIADEMA PARTNERS LP 02/17/2026 316.70 K $11.14 M   100.00% 0.28%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 02/12/2026 316.25 K $11.13 M   2.60% 0.28%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 313.49 K $11.03 M   100.00% 0.28%
AMERICAN CENTURY COMPANIES INC 02/13/2026 305.37 K $10.74 M   3.10% 0.27%

Viking Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 532 institutional investors and hedge funds held shares of Viking Therapeutics Inc. The most heavily invested institutionals were:

UBS Group AG: 1.35 M

Pictet Asset Management Holding SA: 696,301

PRINCIPAL FINANCIAL GROUP INC: 525,484

Bank of New York Mellon Corp: 454,063

Concurrent Investment Advisors, LLC: 347,786

WASATCH ADVISORS LP: 313,158

64.04% of Viking Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 82.14 M shares in the last 24 months. This purchase volume represents approximately $2.76 B in transactions.